These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
240 related items for PubMed ID: 16419109
1. Evaluation of apoptosis in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Kawada J, Kimura H, Shibata Y, Hara S, Hoshino Y, Kojima S, Nishikawa K, Morishima T. J Med Virol; 2006 Mar; 78(3):400-7. PubMed ID: 16419109 [Abstract] [Full Text] [Related]
2. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan. Ohga S, Kudo K, Ishii E, Honjo S, Morimoto A, Osugi Y, Sawada A, Inoue M, Tabuchi K, Suzuki N, Ishida Y, Imashuku S, Kato S, Hara T. Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139 [Abstract] [Full Text] [Related]
3. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis. Toga A, Wada T, Sakakibara Y, Mase S, Araki R, Tone Y, Toma T, Kurokawa T, Yanagisawa R, Tamura K, Nishida N, Taneichi H, Kanegane H, Yachie A. J Infect Dis; 2010 Jun 15; 201(12):1923-32. PubMed ID: 20443735 [Abstract] [Full Text] [Related]
5. Association of transforming growth factor-beta1 gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases. Hatta K, Morimoto A, Ishii E, Kimura H, Ueda I, Hibi S, Todo S, Sugimoto T, Imashuku S. Haematologica; 2007 Nov 15; 92(11):1470-4. PubMed ID: 18024394 [Abstract] [Full Text] [Related]
11. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection. Raghuraman S, Abraham P, Daniel HD, Ramakrishna BS, Sridharan G. J Clin Virol; 2005 Sep 15; 34(1):63-70. PubMed ID: 16087126 [Abstract] [Full Text] [Related]
12. A case of hemophagocytic lymphohistiocytosis after the primary Epstein-Barr virus infection. Kitazawa Y, Saito F, Nomura S, Ishii K, Kadota E. Clin Appl Thromb Hemost; 2007 Jul 15; 13(3):323-8. PubMed ID: 17636196 [Abstract] [Full Text] [Related]
13. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center. Imashuku S, Kuriyama K, Sakai R, Nakao Y, Masuda S, Yasuda N, Kawano F, Yakushijin K, Miyagawa A, Nakao T, Teramura T, Tabata Y, Morimoto A, Hibi S. Med Pediatr Oncol; 2003 Aug 15; 41(2):103-9. PubMed ID: 12825212 [Abstract] [Full Text] [Related]
15. Soluble TWEAK is markedly elevated in hemophagocytic lymphohistiocytosis. Nagasawa M, Yi Z, Imashuku S, Nonoyama S, Ogawa K, Okumura K, Mizutani S. Am J Hematol; 2008 Mar 15; 83(3):222-5. PubMed ID: 17918252 [Abstract] [Full Text] [Related]
16. Clinical significance of clonality and Epstein-Barr virus infection in adult patients with hemophagocytic lymphohistiocytosis. Ahn JS, Rew SY, Shin MG, Kim HR, Yang DH, Cho D, Kim SH, Bae SY, Lee SR, Kim YK, Kim HJ, Lee JJ. Am J Hematol; 2010 Sep 15; 85(9):719-22. PubMed ID: 20652965 [Abstract] [Full Text] [Related]
17. [Five adult cases of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis]. Abe Y, Shiratsuchi M, Nagasawa E, Ohtsuka R, Kiyasu J, Sada E, Idutsu K, Kotoh K, Nishimura J, Ohga S, Takayanagi R. Rinsho Ketsueki; 2010 Jan 15; 51(1):74-9. PubMed ID: 20134144 [Abstract] [Full Text] [Related]